Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model
Fairtility · NCT07017972
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 4000
- US sites recruiting
- 1
- Study start
- June 20, 2025
- Record last updated
- August 7, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software.
In addition, the professional user simulated use will ensure correct and easy use of the AI applications.
Being studied: AI evaluation of embryos
Conditions: Fertility Disorders
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Images and data of eggs or embryos available from egg retrievals by women undergoing standard egg-freezing or In vitro fertilization (IVF) treatments, using their own eggs or donor eggs.
- Women at least 18 years of age.
- Embryos or eggs cultured in a time-lapse incubator connected to the AI Embryo Viewer.
Exclusion Criteria
- Women with no available own or donor eggs.
Recruiting US locations
New England Fertility Institute
Stamford, CT 06905
Site contact: Raga Rohaeim, MSc · 203-325-3200 · raga.rohaiem@nefertility.com
Study contacts (from the official record)
- Pedro Pini, M.D · +541144704026 · pedrogpini@gmail.com
Similar studies in Connecticut
All healthy volunteers studies in Connecticut →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Pfizer
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersEarly Phase 1Overnight stay mentioned
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
Yale University
- Location
- New Haven, CT
- Eligibility basics
- Ages 21–70
- RecruitingHealthy volunteersPhase 1
MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD)
XingImaging, LLC
- Location
- New Haven, CT
- Eligibility basics
- Ages 40–80
- RecruitingHealthy volunteersEarly Phase 1
A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers
Ratio Therapeutics, Inc.
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–60